Cargando…
Multi-Institutional Study Validates Safety of Intraoperative Cesium-131 Brachytherapy for Treatment of Recurrent Head and Neck Cancer
INTRODUCTION: Surgery is the primary treatment for resectable, non-metastatic recurrent head and neck squamous cell carcinoma (HNSCC). We explore the safety and oncologic benefit of intraoperative Cesium-131 (Cs-131) brachytherapy combined with salvage local and/or regional surgical resection. METHO...
Autores principales: | Luginbuhl, Adam, Calder, Alyssa, Kutler, David, Zender, Chad, Wise-Draper, Trisha, Patel, Jena, Cheng, Michael, Karivedu, Vidhya, Zhan, Tingting, Parashar, Bhupesh, Gulati, Shuchi, Yao, Min, Lavertu, Pierre, Takiar, Vinita, Tang, Alice, Johnson, Jennifer, Keane, William, Curry, Joseph, Cognetti, David, Bar-Ad, Voichita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660666/ https://www.ncbi.nlm.nih.gov/pubmed/34900741 http://dx.doi.org/10.3389/fonc.2021.786216 |
Ejemplares similares
-
Cesium-131 Interstitial Brachytherapy for Recurrent Malignancies of Skull Base
por: Savard, Corey, et al.
Publicado: (2019) -
A systematic review of treating recurrent head and neck cancer: a reintroduction of brachytherapy with or without surgery
por: Rodin, Julianna, et al.
Publicado: (2018) -
Cesium-131 brachytherapy in high risk and recurrent head and neck cancers: first report of long-term outcomes
por: Pham, Anthony, et al.
Publicado: (2015) -
A nomogram to determine required seed air kerma strength in planar (131)Cesium permanent seed implant brachytherapy
por: Hubley, Emily, et al.
Publicado: (2019) -
Carotid dosimetry after re-irradiation with (131)Cs permanent implant brachytherapy in recurrent, resected head and neck cancer
por: Walsh, Amanda, et al.
Publicado: (2019)